Search

everythinglearnresearchcommunity

for

Search:↓

The document is a detailed medical reference on skin and genetic disorders.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The document explains various skin conditions and their treatments.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

BMP signaling controls hair growth and skin color.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

IL-17 and certain immune cells are linked to more severe alopecia areata.

PRP treatment may help with alopecia areata, especially in newer cases.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.